Vermeulen M, Le Pesteur F, Gagnerault M C, Mary J Y, Sainteny F, Lepault F
CNRS URA 1461, Université Paris V, Hôpital Necker, Paris, France.
Blood. 1998 Aug 1;92(3):894-900.
Bone marrow (BM) transplantation still must overcome multiple difficulties and should benefit from better understanding of stem-cell homing and mobilization. Here, we analyzed the involvement of several adhesion molecules in the two processes by treating mice with monoclonal antibodies against these molecules. Treatment of lethally irradiated mice grafted with isogeneic BM cells showed that at least two migration pathways are important for stem-cell homing to the BM, whereas only one of them is involved in lodging of colony-forming unit-spleen (CFU-S) in the spleen. We confirm that the VLA-4/VCAM-1 adhesion pathway is important for stem-cell homing to the BM only and show that CD44 is involved in CFU-S lodging in both BM and spleen. These results show that entry of CFU-S into the spleen is regulated. The observation that when one migration pathway is altered, CFU-S do not enter the BM via the other pathway may indicate that the two mechanisms involved in CFU-S homing into the BM are linked. The adhesion molecules VLA-4 and CD44 are also implied in the mobilization of stem cells into the blood stream of mice injected once with anti-VLA-4 or anti-CD44. Anti-VLA-4 administration led to a significant increase in circulating stem cells as early as 8 hours after treatment. Stem cells mobilized by anti-VLA-4 comprise cells with high self-renewal potential and thus may be used for long-term reconstitution of the hematopoietic tissue.
骨髓(BM)移植仍必须克服多重困难,且应受益于对干细胞归巢和动员的更深入理解。在此,我们通过用针对这些分子的单克隆抗体处理小鼠,分析了几种黏附分子在这两个过程中的作用。对接受同基因BM细胞移植的致死性照射小鼠进行处理后发现,至少有两条迁移途径对干细胞归巢至BM很重要,而其中只有一条途径参与集落形成单位-脾(CFU-S)在脾脏中的着床。我们证实VLA-4/VCAM-1黏附途径仅对干细胞归巢至BM很重要,并表明CD44参与CFU-S在BM和脾脏中的着床。这些结果表明CFU-S进入脾脏是受调控的。当一条迁移途径改变时,CFU-S不会通过另一条途径进入BM,这一观察结果可能表明参与CFU-S归巢至BM的两种机制是相关联的。黏附分子VLA-4和CD44也与单次注射抗VLA-4或抗CD44的小鼠体内干细胞向血流中的动员有关。抗VLA-4给药后,早在治疗后8小时循环干细胞就显著增加。由抗VLA-4动员的干细胞包含具有高自我更新潜能的细胞,因此可用于造血组织的长期重建。